The nCounter v2 Cancer CN Assay panel consists of 87 target genes and is intended for CNV genotyping of tumors with various profiles of aberrations in the PIK3CA, AKT, PTEN, BRCA, ERBB2, and MYC genes. This evidence concerns the gene ERBB2 and cancer.